These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38464191)

  • 21. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
    Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Pre-Pandemic Trivalent COBRA HA Vaccine in Mice Pre-Immune to Historical H1N1 and H3N2 Influenza Viruses.
    Ge P; Ross TM
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies.
    Shi H; Zhang X; Ge P; Meliopoulos V; Freiden P; Livingston B; Schultz-Cherry S; Ross TM
    Hum Vaccin Immunother; 2024 Dec; 20(1):2356269. PubMed ID: 38826029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.
    Ross TM; DiNapoli J; Giel-Moloney M; Bloom CE; Bertran K; Balzli C; Strugnell T; Sá E Silva M; Mebatsion T; Bublot M; Swayne DE; Kleanthous H
    Vaccine; 2019 Apr; 37(17):2369-2376. PubMed ID: 30905528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant.
    Gallovic MD; Junkins RD; Sandor AM; Pena ES; Sample CJ; Mason AK; Arwood LC; Sahm RA; Bachelder EM; Ainslie KM; Sempowski GD; Ting JP
    J Control Release; 2022 Jul; 347():356-368. PubMed ID: 35569585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Bertran K; Kassa A; Criado MF; Nuñez IA; Lee DH; Killmaster L; Sá E Silva M; Ross TM; Mebatsion T; Pritchard N; Swayne DE
    Vaccine; 2021 Apr; 39(14):1933-1942. PubMed ID: 33715903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections.
    Nuñez IA; Huang Y; Ross TM
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutinin.
    Batty CJ; Amouzougan EA; A Carlock M; Ross TM; Bachelder EM; Ainslie KM
    Int J Pharm; 2023 Jan; 630():122429. PubMed ID: 36436743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses.
    Uno N; Ross TM
    Sci Rep; 2024 Jan; 14(1):1440. PubMed ID: 38228649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human COBRA 2 vaccine contains two major epitopes that are responsible for eliciting neutralizing antibody responses against heterologous clades of viruses.
    Nuñez IA; Ross TM
    Vaccine; 2020 Jan; 38(4):830-839. PubMed ID: 31733946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.
    Allen JD; Owino SO; Carter DM; Crevar CJ; Reese VA; Fox CB; Coler RN; Reed SG; Baldwin SL; Ross TM
    Vaccine; 2017 Sep; 35(38):5209-5216. PubMed ID: 28789850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020.
    Allen JD; Ross TM
    Front Immunol; 2024; 15():1334670. PubMed ID: 38533508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterologous prime-boost H1N1 vaccination exacerbates disease following challenge with a mismatched H1N2 influenza virus in the swine model.
    Pliasas VC; Neasham PJ; Naskou MC; Neto R; Strate PG; North JF; Pedroza S; Chastain SD; Padykula I; Tompkins SM; Kyriakis CS
    Front Immunol; 2023; 14():1253626. PubMed ID: 37928521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Humoral Response to the Acetalated Dextran M2e Vaccine is Enhanced by Antigen Surface Conjugation.
    Batty CJ; Pena ES; Amouzougan EA; Moore KM; Ainslie KM; Bachelder EM
    Bioconjug Chem; 2023 Aug; 34(8):1447-1458. PubMed ID: 37458383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.
    Giles BM; Bissel SJ; Dealmeida DR; Wiley CA; Ross TM
    Clin Vaccine Immunol; 2012 Feb; 19(2):128-39. PubMed ID: 22190399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Computationally Optimized Broadly Reactive Hemagglutinin and Neuraminidase Vaccine Boosts Antibody-Secreting Cells and Induces a Robust Serological Response, Preventing Lung Damage in a Pre-Immune Model.
    Ge P; Mota YC; Richardson RA; Ross TM
    Vaccines (Basel); 2024 Jun; 12(7):. PubMed ID: 39066344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.